Related Experiment Video
Updated: Aug 7, 2025
12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
1.2K
CD4+ T cells in cancer.
Daniel E Speiser1, Obinna Chijioke2,3, Karin Schaeuble4
1Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland. doc@dspeiser.ch.
Nature Cancer
|March 9, 2023
Summary
CD4+ T cells are crucial coordinators of immune responses and are now recognized as potent anti-tumor effector cells. Understanding their role in cancer offers new therapeutic strategies.
Area of Science:
- Oncology
- Immunology
Background:
- Cancer immunology research predominantly focuses on CD8+ T cells and the tumor microenvironment.
- CD4+ T cells are increasingly recognized for their significant role in coordinating immune responses.
Purpose of the Study:
- To review the current understanding of CD4+ T cells in the context of cancer.
- To highlight the potential of CD4+ T cells in advancing cancer therapies.
Main Methods:
- Literature review of recent advancements in cancer immunology.
- Analysis of the role of CD4+ T cells in anti-tumor immunity.
Main Results:
- CD4+ T cells are central coordinators of both innate and antigen-specific immune responses.
- CD4+ T cells possess intrinsic anti-tumor effector functions.
Conclusions:
- CD4+ T cells are vital players in anti-tumor immunity.
- Further research into CD4+ T cells promises to improve cancer treatment strategies.
More Related Videos
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
01:24T Cell Types and Functions
1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
01:27Tumor Immunotherapy
606
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
606
01:22T Cell Activation and Clonal Selection
1.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
1.8K
01:40Cell-mediated Immune Responses
69.5K
Overview
69.5K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K